Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4639290 | 1.00 | LMNA (0.54) | LMNAMAPK1CYP2D6SRCALDH1A1 | |
| SCHEMBL9450740 | 0.79 | SRC (0.52) | LMNAMAPK1CYP2D6SRC | |
| SCHEMBL4637532 | 0.78 | KMT2A (0.58) | LMNACYP2D6ALDH1A1ADRA2AADRA2C | |
| SCHEMBL5860565 | 0.78 | KMT2A (0.58) | LMNACYP2D6ALDH1A1ADRA2AADRA2C | |
| SCHEMBL3805251 | 0.76 | LMNA (0.58) | LMNAMAPK1CYP2D6SRCALDH1A1 | |
| SCHEMBL3192877 | 0.76 | LMNA (0.58) | LMNAMAPK1CYP2D6SRCALDH1A1 | |
| SCHEMBL6560616 | 0.76 | LMNA (0.58) | LMNAMAPK1CYP2D6SRCALDH1A1 | |
| SCHEMBL6752658 | 0.76 | LMNA (0.58) | LMNAMAPK1CYP2D6SRCALDH1A1 | |
| SCHEMBL4608564 | 0.75 | LMNA (0.52) | LMNAMAPK1CYP2D6ALDH1A1ADRA2A | |
| SCHEMBL27638562 | 0.75 | MMP8 (0.51) | MAPK1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1601778-B1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | COUNCIL SCIENT IND RES (IN) | 2008-07-02 | — | — | EP | disclosed |
| EP-1601778-A1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | Council of Scientific and Industrial Research (IN) | 2005-12-07 | — | — | EP | disclosed |
| US-20040259943-A1 | Stereoselective chemoenzymatic process for the preparation of optically enriched phenylglycidates as precursors of taxol side chain | COUNCIL OF SCIENTIFIC AND INDUSTRIAL (IN) | 2004-12-23 | — | — | US | disclosed |
| WO-2004081219-A1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259943-A1 | Stereoselective chemoenzymatic process for the preparation of optically enriched phenylglycidates as precursors of taxol side chain | GMDS, GPI, B3GAT3 | LMNA 2836/4885MAPK1 1838/4885CYP2D6 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.